PULMONX CORPORATION Debt Securities, Available-for-sale, Allowance for Credit Loss
PULMONX CORPORATION (LUNG) had Debt Securities, Available-for-sale, Allowance for Credit Loss of $0 as of 2023-06-30, per its 10-Q filed 2023-08-04.
Discontinued › Notes › Credit Losses
us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss · last filed 2023-08-04
- 2023-06-30: Debt Securities, Available-for-sale, Allowance for Credit Loss $0.00.
- 2023-03-31: Debt Securities, Available-for-sale, Allowance for Credit Loss $0.00.
- 2022-12-31: Debt Securities, Available-for-sale, Allowance for Credit Loss $0.00.
| Period end | Debt Securities, Available-for-sale, Allowance for Credit Loss |
|---|---|
| 2023-06-30 | $0.00 10-Q · filed 2023-08-04 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-08 |
| 2022-12-31 | $0.00 10-Q · filed 2023-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |